Heather Ashton

Source: Wikipedia, the free encyclopedia.
Heather Ashton
Born
Chrystal Heather Champion

(1929-07-11)11 July 1929
Dehradun, British India
Died15 September 2019(2019-09-15) (aged 90)
Newcastle upon Tyne, England
Alma materSomerville College, Oxford
Scientific career
FieldsMedicine, Psychopharmacology
InstitutionsNewcastle University

Heather Ashton

FRCP (11 July 1929 – 15 September 2019) was a British psychopharmacologist and physician.[1][2] She is best known for her clinical and research work on benzodiazepine dependence.[1][2][3][4]

Biography

Chrystal Heather Champion was born in Dehradun, northern India, to Harry Champion, a British silviculturist, and Chrystal (Parsons) Champion, a secretary.[1][2][4] From the age of six, she attended a boarding school in Swanage, Dorset, England.[1] When WWII began, she was evacuated to West Chester, Pennsylvania; during the crossing, her ship was attacked by a U-boat.[1]

Ashton went on to study Medicine at

first class honours Bachelor of Arts (BA) degree in physiology in 1951.[3] She earned her Bachelor of Medicine, Bachelor of Surgery (BM BCh) degrees in 1954 and a postgraduate Doctor of Medicine (DM) degree in 1956.[3] She completed professional training at Middlesex Hospital.[1] She was elected as a Fellow of the Royal College of Physicians, London, in 1975.[3]

In 1965, Ashton joined the faculty at Newcastle University, first in the Department of Pharmacology and later in the Department of Psychiatry.[1][3] From 1982 to 1994, she ran a benzodiazepine withdrawal clinic at the Royal Victoria Infirmary in Newcastle.[2] She was on the executive committee of the North East Council on Addictions.[1][5] Ashton also helped set up the British organisation Victims of Tranquillisers (VOT).[3][6] She also gave evidence to British government committees on tobacco smoking, cannabis and benzodiazepines.[3][7]

Ashton died on 15 September 2019 at her home in Newcastle upon Tyne, at age 90.[2]

Research

Ashton's developed her expertise in the effects of psychoactive drugs and the effects of substances such as nicotine and cannabis on the brain.[1]

During the 1960s, benzodiazepines, like diazepam and temazepam, had become popular and were seen as safe and effective treatments for anxiety or insomnia.[1][2][4] One study found that the overdose death rate among patients taking both benzodiazepines and opioids was 10 times higher than among those who only took opioids.[2]

Ashton's research on these drugs found that they could be used in the short term, but could lead to physical dependence over the long-term.

psychotropic drugs led to over 200 journal articles, chapters and books, including over 50 papers concerning benzodiazepines alone.[4]

References

  1. ^
    ISSN 0261-3077
    . Retrieved 2020-01-06.
  2. ^
    ISSN 0362-4331
    . Retrieved 2020-01-06.
  3. ^ a b c d e f g h "Professor C Heather Ashton, DM, FRCP – CV". benzo.org.uk. Retrieved 2020-01-06.
  4. ^ a b c d "Heather Ashton obituary". Foundation for Excellence in Mental Health Care. 2019-11-18. Retrieved 2020-01-06.
  5. ^ "Neca Homepage". Neca.
  6. ^ "Victims of Tranquillisers – Objectives & Activities". benzo.org.uk.
  7. ^ a b "Benzodiazepines: How They Work & How to Withdraw". benzo.org.uk.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Heather_Ashton&oldid=1185197678"